Related Experiment Video
Updated: May 9, 2025

In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium
Published on: May 6, 2018
Effects of Long-Acting Anticoagulant Rodenticides on Rabbit Plasma Extracellular Vesicles
Intakhar Ahmad1,2, Ruth N Muchiri3, Richard B van Breemen3
1Department of Anesthesiology, University of Illinois College of Medicine, Chicago, Illinois 60612, United States.
Long-acting anticoagulant rodenticides (LAARs) alter extracellular vesicle (EV) concentration and size, potentially facilitating toxicant transport. Cholestyramine treatment partially reversed these EV changes, suggesting a role in mitigating LAAR toxicity.
Area of Science:
- Environmental Toxicology
- Cellular Biology
- Biochemistry
Background:
- Extracellular vesicles (EVs) are crucial for intercellular communication and can transport substances across biological barriers, including the blood-brain barrier.
- Environmental toxicants can alter EV production and composition, impacting their physiological roles.
- Long-acting anticoagulant rodenticides (LAARs) pose a public health risk due to their persistence and potential toxicity.
Purpose of the Study:
- To investigate the impact of LAARs on plasma EV dynamics in rabbits.
- To determine if cholestyramine (CSA) affects LAAR-induced changes in EVs.
- To assess the association of LAARs with EVs and the functional consequences of EV alterations.
Main Methods:
- Plasma EVs were isolated from rabbits exposed to a mixture of three potent LAARs (brodifacoum, difenacoum, bromadiolone) using polymer-based precipitation.
- Nanoparticle tracking analysis (NTA) was used to quantify EV concentration and size distribution.
- Mass spectrometry identified LAARs associated with EVs, and their effects on microglial cells were assessed.
Main Results:
- LAAR exposure led to a time-dependent decrease in EV concentration and altered EV size distribution.
- Co-administration of CSA reversed some LAAR-induced EV alterations.
- All three LAARs were detected in isolated EVs, and CSA reduced their levels; EVs from LAAR-treated rabbits induced microglial cell death.
Conclusions:
- LAARs significantly influence the concentration and size of circulating EVs.
- EVs may serve as a mechanism for transporting LAARs throughout the body, contributing to their toxicity.
- CSA demonstrates potential in mitigating LAAR effects on EVs and possibly reducing systemic toxicant distribution.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

